Skip to main content
Equibles

MDNC · Medinotec Inc. · Metrics

Track MDNC — free

Use MDNC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDNC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.00 At close · Apr 14
Rebalance outlook locked
Market Cap
$58.78M
Shares
11.76M
Volume · Apr 14 100 Avg daily vol (1 sessions) 100

MDNC metrics

37 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$5.00
Market cap
$58.78M

Price action

20 metrics
Price change (1W)
—
Price change (30D)
—
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
11.76M

Valuation

12 metrics
P / E (TTM)
65.1
Trailing earnings · reciprocal yield 1.5%
PEG ratio
1.3
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
5.7×
reciprocal yield 17.4%
P / book
10.0
reciprocal yield 10.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
39.5
reciprocal yield 2.5%
Earnings yield
1.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
53.9%
Operating margin
9.7%
Trailing 12 months
Net margin
8.8%
Gross profit (TTM)
$5.52M
Operating profit (TTM)
$997,927
Net income (TTM)
$902,732
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.49

Growth

11 metrics
Revenue growth YoY
+24.2%
Year over year
Net income growth YoY
+95.1%
Revenue (TTM)
$10.25M
Trailing 12 months
EPS growth YoY
+50.0%
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
+113.5%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
15.4%
Return on assets
12.9%
Debt / equity
—
Current ratio
5.8
EBITDA (TTM)
$1.09M
Free cash flow (TTM)
—
Quick ratio
5.8
Interest coverage
16.0
Net debt / EBITDA
-2.3
Return on invested capital
—
Trailing 12 months
Net cash
$2.52M
Latest balance sheet
Cash & equivalents
$2.52M
Total assets
$6.99M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.49M
Capital expenditures (TTM)
—
R&D (TTM)
$108,814
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
1.1%
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1931055 Visit website Investor relations